Found 13 matching trials
Factor Xa Inhibitor, PRT054021, Against Enoxaparin for the Prevention of Venous Thromboembolic Events (EXPERT) PHASE2 Randomized study of PRT054021 40 mg and 15 mg bid vs. enoxaparin 30 mg q12h...
Show More Location
Montreal General Hospital
Learn More & Join Trial
Safety and Efficacy of TeaRx Xa Factor Direct Inhibitor Versus Enoxaparin as a Venous Thromboembolic Events (VTE) Prevention Following Total Knee Replacement PHASE2 To evaluate influence of therapy on the following efficacy and safety param...
Show More Location
SHAI "Republican Clinical Hospital of the Ministry of Health of the Republic of Tatarstan"
Learn More & Join Trial
Warfarin Initiation in Mechanical Mitral Valve Replacement Patients PHASE4 A prospective, comparative study evaluating warfarin initiation in a dose o...
Show More Location
The Cardiovascular Hospital
Learn More & Join Trial
Evaluation of Venous Thromboembolism Prevention in High-Risk Trauma Patients PHASE4 This is a pilot study to determine if anti-thrombin III (AT-III) serum conc...
Show More Location
University of Cincinnati Medical Center
Learn More & Join Trial
FREEDOM COVID-19 Anticoagulation Strategy PHASE4 Coronavirus Disease (COVID-19), caused by severe acute respiratory syndrome...
Show More Location
Icahn School of Medicine at Mount Sinai
Learn More & Join Trial
Catheter-Related Early Thromboprophylaxis With Enoxaparin (CRETE) Trial PHASE2 The purpose of this phase 2a, multi-center, randomized controlled study, is...
Show More Location
Yale University Yale New Haven Health
Learn More & Join Trial
Patients With High-risk Acute Coronary Syndrome Without ST-segment Elevation PHASE3 This non-inferiority study aims at comparing Versa® to the reference enoxap...
Show More Location
Multiple Locations
Learn More & Join Trial
Prevention of Arteriovenous Thrombotic Events in Critically-Ill COVID-19 Patients Trial PHASE4 The researchers wanted to learn how to help sick patients who are in the ho...
Show More Location
Brigham and Women's Hospital
Learn More & Join Trial
Intermediate or Prophylactic-Dose Anticoagulation for Venous or Arterial Thromboembolism in Severe COVID-19 PHASE4 This study is being conducted to assess the effectiveness of intermediate v...
Show More Location
Columbia University Medical Center
Learn More & Join Trial
Individual Dose Adjustment of Low-molecular-weight-heparin by Thromodynamics Test. PHASE4 The aim of this study is to evaluate the efficacy and safety of individual ...
Show More Location
Moscow Clinical Hospital no.24
Learn More & Join Trial